US Halts Use of Johnson & Johnson COVID-19 Vaccine Following Rare, Severe Blood Clots
The FDA and the CDC are requesting that the Johnson & Johnson vaccine be halted in the US after six women developed rare blood clots.
Full Article
US Halts Use of Johnson & Johnson COVID-19 Vaccine Following Rare, Severe Blood Clots
HNGN
0 shares
2 views
You might like
Related news coverage
California man hospitalized with clot after J&J vaccination
SeattlePI.com
SAN FRANCISCO (AP) — A San Francisco Bay Area man in his 30s is recuperating after developing a rare blood clot in his leg within..
-
News24.com | US ends J&J Covid-19 vaccine pause, shots to resume immediately
News24
-
CDC Panel Recommends Lifting Pause On J&J Vaccine
Newsy
-
U.S. health panel says it's time to restart Johnson & Johnson COVID-19 vaccinations
CBC.ca
-
U.S. health panel urges restarting J&J COVID-19 vaccinations
CTV News
Advertisement
More coverage
US health panel urges restarting J&J Covid-19 vaccinations
Belfast Telegraph
A US health panel says it is time to resume use of Johnson & Johnson’s Covid-19 vaccine, despite a very rare risk of blood clots.
-
US health panel reviews J&J vaccine pause over rare clots
SeattlePI.com
-
EU agency says people should get 2nd dose of AstraZeneca too
SeattlePI.com
-
EU agency to issue more guidance on AstraZeneca's COVID shot
SeattlePI.com
-
Oregon: CDC investigating woman's death after J&J vaccine
SeattlePI.com